Tanta University

Cardioprotection Effect of Linagliptin

Phase 3Not yet recruiting2026140 people1 Oct 2026clinicaltrials.gov

NCT07815808

Phase 3Not yet recruiting2026150 people11 Sept 2026clinicaltrials.gov

NCT07811011

Phase 2/3Not yet recruiting202670 people9 Sept 2026clinicaltrials.gov

NCT07810998

Phase 2/3Not yet recruiting202660 people9 Sept 2026clinicaltrials.gov

NCT07644520

Phase 2/3Not yet recruiting2026150 people12 Jun 2026clinicaltrials.gov

NCT07572552

Phase 2Not yet recruiting202666 people7 May 2026clinicaltrials.gov

NCT07504198

Phase 2/3Not yet recruiting202646 people31 Mar 2026clinicaltrials.gov

NCT07436663

Phase 4Not yet recruiting2026150 people27 Feb 2026clinicaltrials.gov

NCT07372040

Phase 2Recruiting202666 people28 Jan 2026clinicaltrials.gov

NCT07370506

Phase 1/2Not yet recruiting202636 people27 Jan 2026clinicaltrials.gov

NCT07293910

Phase 2Recruiting2026132 people19 Dec 2025clinicaltrials.gov

NCT07275827

Phase 3Recruiting202688 people10 Dec 2025clinicaltrials.gov

NCT07246278

Phase 1/2Recruiting202580 people24 Nov 2025clinicaltrials.gov

NCT07241247

Phase 4Completed202444 people21 Nov 2025clinicaltrials.gov

NCT07239011

Phase 1/2Recruiting202560 people20 Nov 2025clinicaltrials.gov

NCT07229651

Phase 2/3Recruiting202560 people17 Nov 2025clinicaltrials.gov

NCT07157722

Phase 3Not yet recruiting202566 people5 Sept 2025clinicaltrials.gov

NCT07145268

Phase 2Not yet recruiting202544 people28 Aug 2025clinicaltrials.gov

NCT07097727

Phase 1Completed202370 people31 Jul 2025clinicaltrials.gov

NCT07025005

Phase 4Recruiting202544 people17 Jun 2025clinicaltrials.gov